New Study to Explore AI’s Role, Next-Generation Virtual Classrooms, in Shaping the Future of Higher Education
Casey Green, Founder of The Campus Computing Project to Publish Research on the Impact of…
News
5G Network Technology and High-Speed Data Communications Fueling Growth in the RAN Market – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Radio Access Network – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s…
Capricor Therapeutics Announces Late-Breaking Presentations at 28th Annual Congress of the World Muscle Society
-24-Month Open Label Extension Data from HOPE-2 Study Supports CAP-1002’s Sustained Efficacy and Safety in…
Capricor Therapeutics Announces Late-Breaking Presentations at 28th Annual Congress of the World Muscle Society
-24-Month Open Label Extension Data from HOPE-2 Study Supports CAP-1002’s Sustained Efficacy and Safety in…
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
Veteran Life Sciences Executives Bring Extensive Public Company Operating Experience to Leadership Team CINCINNATI, Oct….
Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO
Veteran Life Sciences Executives Bring Extensive Public Company Operating Experience to Leadership Team CINCINNATI, Oct….
Carmot Therapeutics Announces that Preliminary Phase 1 Results Support Once-daily Oral Dosing for its Obesity and Type 2 Diabetes Candidate CT-996
BERKELEY, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — Carmot Therapeutics, Inc. (Carmot), a clinical-stage biotechnology…
Carmot Therapeutics Announces that Preliminary Phase 1 Results Support Once-daily Oral Dosing for its Obesity and Type 2 Diabetes Candidate CT-996
BERKELEY, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — Carmot Therapeutics, Inc. (Carmot), a clinical-stage biotechnology…
Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England’s Generation Study of Rare Conditions
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
Inozyme Pharma Highlights Inclusion of Generalized Arterial Calcification of Infancy (GACI) in Genomics England’s Generation Study of Rare Conditions
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY) (“Inozyme” or the “Company”),…
American Journal of Respiratory and Critical Care Medicine Publishes Full, Positive Results of Apnimed’s MARIPOSA Study on AD109, an Investigational Oral Drug for Obstructive Sleep Apnea
— Phase 3 Clinical Trials for AD109 Currently Enrolling Patients in the U.S. CAMBRIDGE, Mass.,…
Helsinn closes financing agreement with BancaStato to support business objectives and growth
Helsinn closes financing agreement with BancaStato to support business objectives and growth New funding secured…
American Journal of Respiratory and Critical Care Medicine Publishes Full, Positive Results of Apnimed’s MARIPOSA Study on AD109, an Investigational Oral Drug for Obstructive Sleep Apnea
— Phase 3 Clinical Trials for AD109 Currently Enrolling Patients in the U.S. CAMBRIDGE, Mass.,…
Helsinn closes financing agreement with BancaStato to support business objectives and growth
Helsinn closes financing agreement with BancaStato to support business objectives and growth New funding secured…
Cerevance to Participate at the 3rd Annual Needham Biotech Private Company Forum
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
Cerevance to Participate at the 3rd Annual Needham Biotech Private Company Forum
BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development…
Aruna Bio to Participate in the BIO Investor Forum in October 2023
BOSTON and ATHENS, Ga., Oct. 10, 2023 (GLOBE NEWSWIRE) — Aruna Bio, Inc., a leader…
Aruna Bio to Participate in the BIO Investor Forum in October 2023
BOSTON and ATHENS, Ga., Oct. 10, 2023 (GLOBE NEWSWIRE) — Aruna Bio, Inc., a leader…
Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress
“VANQUISH” Clinical Trial (n=40) suggests safety and efficacy of nVNS for the Treatment of Headache…
Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress
“VANQUISH” Clinical Trial (n=40) suggests safety and efficacy of nVNS for the Treatment of Headache…